Analyzing the structural details of viral proteins makes it possible to identify specific therapeutic targets, which are fundamental for developing antivirals. Considering the global increase in arboviruses like dengue, Zika, and chikungunya, a structural approach offers crucial insights for planning innovative therapeutic interventions in order to mitigate the impact of these emerging diseases and reinforce preparation for future viral threats.

Within this context, LNBio directs its efforts toward analyzing viral proteins, using sophisticated techniques and advanced virology and mass spectrometry techniques. These tools make it possible to identify targets and develop effective therapeutic solutions, making significant contributions to public health.

meet
our team

Rafael Elias Marques

Lead researcher

virology group
See Lattes CV

All groups in immunity and pathogens